Historical Stock Price
ETFs Holding THRX »    THRX Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $6.58 $6.88 $6.22 $6.52 27.30K
12/05/2022 $6.39 $6.57 $5.88 $6.03 17.20K
12/06/2022 $5.96 $6.16 $5.50 $5.51 40.80K
12/07/2022 $5.69 $6.06 $5.54 $5.80 11.90K
12/08/2022 $5.83 $6.05 $5.55 $5.98 10.80K
Theravance is a royalty management company primarily focused on the respiratory assets partnered with Glaxo Group Limited (GSK). Long-Acting Beta2 Agonist (LABA) Collaboration Agreement with GSK is to develop and commercialize once-daily LABA products for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. For the treatment of COPD, the collaboration has developed two combination products: RELVAR®/BREO® ELLIPTA® (FF/VI) (BREO® ELLIPTA® and RELVAR® ELLIPTA®. For the treatment of asthma, RELVAR® ELLIPTA® is approved in multiple regions outside of North America and the collaboration is further developing FF/VI for the U.S.
THRX historical stock prices picture
Theseus Pharmaceuticals (THRX) has the following price history information. Looking back at THRX historical stock prices for the last five trading days, on December 02, 2022, THRX opened at $6.58, traded as high as $6.88 and as low as $6.22, and closed at $6.52. Trading volume was a total of 27.30K shares. On December 05, 2022, THRX opened at $6.39, traded as high as $6.57 and as low as $5.88, and closed at $6.03. Trading volume was a total of 17.20K shares. On December 06, 2022, THRX opened at $5.96, traded as high as $6.16 and as low as $5.50, and closed at $5.51. Trading volume was a total of 40.80K shares. On December 07, 2022, THRX opened at $5.69, traded as high as $6.06 and as low as $5.54, and closed at $5.80. Trading volume was a total of 11.90K shares. On December 08, 2022, THRX opened at $5.83, traded as high as $6.05 and as low as $5.55, and closed at $5.98. Trading volume was a total of 10.80K shares.

THRX Historical Stock Prices By Date:

THRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Theseus Pharmaceuticals shares, starting with a $10,000 purchase of THRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/07/2021
End date: 12/08/2022
Start price/share: $18.58
End price/share: $5.98
Dividends collected/share: $0.00
Total return: -67.81%
Average Annual Total Return: -62.06%
Starting investment: $10,000.00
Ending investment: $3,218.11
Years: 1.17
Date Close
12/02/2022$6.52
12/05/2022$6.03
12/06/2022$5.51
12/07/2022$5.80
12/08/2022$5.98
THRX is categorized under the Healthcare sector; below are some other companies in the same sector:

TKAI Historical Stock Prices
TKMR Historical Stock Prices
TLB Historical Stock Prices
TLGT Historical Stock Prices
TLOG Historical Stock Prices
TMO Historical Stock Prices
TNDM Historical Stock Prices
TNXP Historical Stock Prices
TOCA Historical Stock Prices
TOS Historical Stock Prices

Email EnvelopeFree THRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

THRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.